Where is Protagonist headquartered?

Protagonist is located in Newark, CA.

Who invested in Protagonist?

Protagonist has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Protagonist?

Protagonist closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

protagonist-inc.com

Protagonist

Protagonist is a California-based biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of gastrointestinal diseases.

Business Model:

Revenue: $35.2M

Employees: 51-200

Geographic Data

Address: 7707 Gateway Boulevard

City: Newark

State: CA

Zip: 94560

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$132M

Raised Total:

$389M

Social

Twitter

Crunchbase

Metrics

3,403,015Website Global Rank

4,603Website Monthly Traffic

Twitter Followers

Description

Protagonist is a California-based biopharmaceutical company that develops and commercializes peptide therapeutics for the treatment of gastrointestinal diseases.

Contact Phone:
+15104740170

Contact Email:

IPO Details

Protagonist went public on 8/18/2016 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/18/2016

Ticker Symbol:
PTGX

Amount Raised:
$90M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/2018	Post-IPO Equity		$22M
7/2015	Series C		$0	Adage Capital Management Canaan Partners Pharmstandard International Starfish Ventures RA Capital Management Inbio Ventures Canaan Partners Lilly Ventures Foresite Capital Johnson &a; Johnson Innovation – JJDC Adage Capital Management Canaan Partners Pharmstandard International Starfish Ventures RA Capital Management Inbio Ventures Canaan Partners Lilly Ventures Foresite Capital Johnson &a; Johnson Innovation – JJDC
5/2017	Grant	1	$1.3M	National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health
9/2006	Series A	3	$9M	Starfish Ventures QIC BioVentures Lilly Ventures
9/2013	Series B	1	$4M	Pharmstandard Pharmstandard
9/2018	Grant	1	$1.4M	National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health
10/2019	Post-IPO Debt	2	$50M	Silicon Valley Bank MidCap Financial MidCap Financial Silicon Valley Bank Silicon Valley Bank MidCap Financial MidCap Financial Silicon Valley Bank
12/2020	Post-IPO Equity		$115M
6/2021	Post-IPO Equity		$132.2M
6/2013	Series B		$0	Johnson &a; Johnson Development Corporation Starfish Ventures Lilly Ventures Inbio Ventures Johnson &a; Johnson Development Corporation Starfish Ventures Lilly Ventures Inbio Ventures
7/2015	Series C	9	$40M	Adage Capital Management Canaan Partners Pharmstandard International Starfish Ventures RA Capital Management Inbio Ventures Canaan Partners Adage Capital Management Canaan Partners Pharmstandard International Starfish Ventures RA Capital Management Inbio Ventures Canaan Partners
6/2013	Series B	4	$14M	Johnson &a; Johnson Development Corporation Johnson &a; Johnson Development Corporation

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details